Anticoagulant and Antiplatelet Therapy Use in 426 Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention and Stent Implantation

Ruiz-Nodar, Juan M., Marín, Francisco, Hurtado, José Antonio, Valencia, José, Pinar, Eduardo, Pineda, Javier, Gimeno, Juan Ramón, Sogorb, Francisco, Valdés, Mariano, Lip, Gregory Y.H.·2008·Journal of the American College of Cardiology
DOI 10.1016/j.jacc.2007.11.035

Cited by (269)

Items 201–269 of 269

  1. Oral Anticoagulants With Dual Antiplatelet Therapy Versus Clopidogrel in Patients After Percutaneous Coronary Intervention: A Meta-Analysis
    Mohan Palla, Αlexandros Briasoulis, Ashok Kondur · 2016 · American Journal of Therapeutics
  2. Real-world antithrombotic therapies and clinical outcomes after second-generation drug-eluting stent implantation in patients with atrial fibrillation: a multi-center cohort study
    H. Otsuki, J. Yamaguchi, K. Kamishima, H. Arashi, N. Hagiwara · 2018 · Heart and Vessels
  3. Triple Therapy: When, if Ever?
    Nino Mihatov, Eric Alexander Secemsky, Sammy Elmariah · 2018 · Current Treatment Options in Cardiovascular Medicine
  4. One Weapon, Two Blows in the War Against the Thrombus
    Srijita Sen‐Chowdhry, Richard J. Gordon · 2014 · Journal of the American College of Cardiology
  5. The Problem of Stent Thrombosis Associated With Drug‐Eluting Stents and the Optimal Duration of Dual Antiplatelet Therapy
    Susana Ayyanathan, David Hersh, Neil L. Coplan, Kirk N. Garratt · 2009 · Preventive Cardiology
  6. Atrial Fibrillation and Percutaneous Coronary Intervention: Stroke, Thrombosis, and Bleeding
    Antonio Gutiérrez, Sunil V. Rao · 2011 · Current Treatment Options in Cardiovascular Medicine
  7. Triple therapy in hospitalized patients: Facts and controversies
    John Fani Srour, Gerald W. Smetana · 2011 · Journal of Hospital Medicine
  8. The potential role of anticoagulant therapy for the secondary prevention of ischemic events post-acute coronary syndrome
    Anthony C. Camuglia, Kathryn E. Waddell-Smith, Christopher J.K. Hammett, Philip E. Aylward · 2014 · Current Medical Research and Opinion
  9. Non-vitamin K antagonist oral anticoagulants (NOACs) in the cardiac catherisation laboratory: Friends or Foes?
    Nay Htun, Karlheinz Peter · 2015 · Thrombosis and Haemostasis
  10. Highlights of the Year in JACC 2008
    Anthony Nicholas DeMaria, Ori Ben‐Yehuda, Jeroen Joost Bax, Gregory K. Feld, Barry Greenberg, Wilbur Y.W. Lew, João A.C. Lima, Alan S. Maisel, Sanjiv M. Narayan, David J. Sahn et al. · 2009 · Journal of the American College of Cardiology
  11. Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registry
    Manel Sabaté, Salvatore Brugaletta, Alexandre Abizaid, ADRIAN P BANNING, Antonio Luca Bartorelli, Vladimír Džavík, Stephen G. Ellis, David R. Holmes, Runlin Gao, Myung Ho Jeong et al. · 2013 · International Journal of Cardiology
  12. Mortality Risk Associated with AF in Myocardial Infarction Patients.
    Rajiv Sankaranarayanan · 2012 · Europe PMC (PubMed Central)
  13. Hemostatic Aspects of Cardiovascular Medicine
    Sreekanth Vemulapalli, Richard Clinton Becker · 2013 · Elsevier eBooks
  14. Impacto del tratamiento antitrombótico y los síndromes geriátricos en octogenarios con fibrilación auricular y cardiopatía isquémica. Fibrilación Auricular y Cardiopatía Isquémica en Longevos (FACIL)
    Clara Bonanad Lozano, Pablo Díez‐Villanueva, Sergio García‐Blas, Ana Ayesta, Sònia Ibars, Albert Ariza‐Solé, José Luis Ferreiro, Raúl Moreno, Inmaculada Roldán, Francisco R. Marín et al. · 2020 · Revista Española de Geriatría y Gerontología
  15. Use of drug-eluting versus bare-metal stents after an acute coronary syndrome in Portugal: The EURHOBOP study
    Vítor Barros, Marta Pereira, Carla Araújo, Pedro Gabriel Senger Braga, Ana Azevedo · 2015 · Revista Portuguesa de Cardiologia (English Edition)
  16. Intracoronary Beta-Radiation Therapy for In-stent Restenosis: Long-Term Success Rate and Prediction of Failure
    Georgios J. Vlachojannis, Stephan Fichtlscherer, Ioakim Spyridopoulos, Wolfgang Auch–Schwelk, Bernd Schopohl, Andreas Michael Zeiher, Volker Schächinger · 2010 · Journal of Interventional Cardiology
  17. Antithrombotic therapy use for patients with atrial fibrillation undergoing percutaneous coronary intervention: new data in an area of limited evidence
    Francisco R. Marín, Paulus F. Kirchhof, Gregory Y.H. Lip · 2009 · EP Europace
  18. Antithrombotic Therapy Use After Percutaneous Coronary Intervention and Stent Implantation in Patients Taking Chronic Oral Anticoagulation
    Juan M. Ruiz-Nodar, Francisco R. Marín, Gregory Y.H. Lip · 2008 · JACC: Cardiovascular Interventions
  19. Heart failure and iron deficiency anaemia: a complex dance
    Thomas Callender, Kazem Rahimi · 2015 · Heart
  20. Atrial fibrillation and coronary artery disease
    Morten Lamberts, Willem Dewilde, Morten Lock Hansen · 2014 · Current Opinion in Cardiology
  21. Patientenauswahl für die Implantation eines Vorhofohr-Okkluders in der Primär- und Sekundärprävention des kardioembolischen Schlaganfalls bei Vorhofflimmern
    Carsten Walter Israel, Denio Adrianus Ridjab, Wladimir N. Tschishow, J. Buddecke · 2013 · Herzschrittmachertherapie + Elektrophysiologie
  22. Management der interventionellen Therapie von Patienten mit akutem Koronarsyndrom und Vorhofflimmern
    Anamaria Wolf-Pütz, M. Wein, R.M. Klein · 2011 · Der Kardiologe
  23. Safety and outcome of coronary interventions with special reference to anticoagulation and stent type
    Antti-Pekka Annala · 2015 · UTUPub (University of Turku)
  24. Antithrombotic and Antiplatelet Therapy in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention
    Karam F. Ayoub, Meera Marji, Ramez S. Nairooz · 2015 · The American Journal of Cardiology
  25. Anti-platelet treatment for acute coronary syndrome in Japan
    Tsukasa Ohmori · 2008 · Japanese Journal of Thrombosis and Hemostasis
  26. Dual Antiplatelet Therapy Plus Oral Anticoagulation: How Does Hemorrhagic Risk Impact Stent Selection?
    Gregory R. Giugliano, Amir S. Lotfi · 2008 · JACC: Cardiovascular Interventions
  27. Fibrillation atriale : qui anticoaguler ?
    Olivier Césari · 2010 · La Presse Médicale
  28. Rapport bénéfice–risque de l’association anticoagulants oraux et antiagrégants plaquettaires chez le sujet âgé : revue de la littérature
    Sélim Omrani, A. Brutel, Renaud Faure, Laurent Bourguignon, Yves Guilhermet, Christelle Mouchoux · 2013 · Le Pharmacien Hospitalier et Clinicien
  29. Voie d’abord radiale et prise en charge des malades sous anticoagulants oraux au long cours en cardiologie interventionnelle
    Pierre‐François Lesault, Emmanuel Teíger · 2009 · Annales de Cardiologie et d Angéiologie
  30. Antithrombotic Therapy After Coronary Artery Stenting in Patients With Atrial Fibrillation
    Michiel Coppens, John W. Eikelboom · 2012 · Circulation Cardiovascular Interventions
  31. A radial resolution to a warfarin worry
    James C. Blankenship, Peter B. Berger · 2014 · Catheterization and Cardiovascular Interventions
  32. Impact of peri-procedural atrial fibrillation (AF) on short-term clinical outcomes following percutaneous coronary intervention (PCI)
    William Chan, Andrew Edward Ajani, David J. Clark, Nick Andrianopoulos, Angela Brennan, Christopher Michael Reid, Gishel New, Peter M. Kistler, Anthony Michael Dart, Stephen James Duffy · 2009 · Heart Lung and Circulation
  33. Questions pratiques dans le traitement de la fibrillation atriale
    Stéphane Éderhy, Sylvie Lang, Nabila Haddour, Louise Boyer-Châtenet, Laurie Soulat-Dufour, Saroumadi Adavane-Scheublé, Guillaume Fleury, C. Van Der Vynckt, Magali Charbonnier, Ciham El Asri et al. · 2013 · Archives of Cardiovascular Diseases Supplements
  34. Is thrombogenesis related to residual platelet function in ischaemic heart disease?
    Francisco J. Pastor‐Pérez, Francisco R. Marín, Sergio Manzano‐Fernández, Gregory Y.H. Lip · 2008 · European Heart Journal
  35. Safety of dual antiplatelet therapy in daily cardiology practice
    Freek W.A. Verheugt · 2010 · Netherlands Heart Journal
  36. Triple Antithrombotic Therapy After Coronary Stenting
    Freek W.A. Verheugt · 2011 · Circulation Cardiovascular Interventions
  37. Étude WOEST : Utilisation du clopidrogrel avec ou sans acide acétylsalicylique pour les patients anticoagulés subissant une intervention coronarienne percutanée
    Mylène Beauchemin, Maya Bystrzycki, Claudie Richer · 2015 · Pharmactuel
  38. I pro e i contro della tripla terapia nel paziente con fibrillazione atriale dopo angioplastica coronarica con impianto di stent
    Gennaro Galasso, Tullio Niglio, Carolina D’Anna, Rossella Luciano, Maurizio Santomauro, Federico Piscione · 2010 · Giornale Italiano di Aritmologia e Cardiostimolazione
  39. Interdisciplinary Council on Quali Blood Pressure Research, Council on Peripheral Vascular Disease, and Cardiovascular Nursing, Council on Epidemiology and Prevention, Council for High and on behalf of the American Heart Association Stroke Council, Council on
    James Frederick Meschia, Wesley S. Moore, Thomas A. Pearson, Robert G. Hart, Judith A. Hinchey, Virginia J. Howard, Edward C. Jauch, Seemant Chaturvedi, Mark A. Creager, Antonio Culebras et al. · 2010
  40. Grupo de Trabajo de Revascularización Miocárdica de la Sociedad Europea de Cardiología (ESC) y la European Association for Cardio-Thoracic Surgery (EACTS) Desarrollada con la colaboración especial de la European Association of Percutaneous Cardiovascular Interventions (EAPCI)
    Stephan Windecker · 2016
  41. Triple Antithrombotic Therapy: Is it Time to Drop the Aspirin?
    Prokopis Papadimitriou · 2015
  42. [How and when to use dual antiplatelet treatment in the patient treated with oral anticoagulants?].
    Andrea Rubboli, Giuseppe Di Pasquale · 2008 · PubMed
  43. [Non valvular atrial fibrillation: the place of the new anticoagulants].
    Thierry Pepersack · 2015 · PubMed
  44. The Combination of Anticoagulants and Platelet Inhibitors Postcoronary Stent Implantation
    Hussam Hamdalla, Steven R. Steinhubl · 2016 · CRC Press eBooks
  45. IN PRACTICE Acute and Chronic Management of Atrial Fibrillation in Patients With Late-Stage CKD
    Wilbert S. Aronow · 2009
  46. Protocolo de tratamiento de la fibrilación auricular
    2010 · FMC - Formación Médica Continuada en Atención Primaria
  47. Does Rivaroxaban Better than Vitamin K Antagonists in Atrial Fibrillation Patients Undergoing PCI?
    M Kara, Omar Aït Mokhtar, Adel Azaza, Saber Seddiki, F. Harbi · 2016 · Archives of Hematology Case Reports and Reviews
  48. Will warfarin become obsolete?
    Wendy A. Leong, Joseph A. Caprini, Debra Hoppensteadt, Jawed Fareed · 2012
  49. Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Bharath Rajagopalan, Christopher A. Madias · 2019 · Current Treatment Options in Cardiovascular Medicine
  50. Impact of Post-Discharge Bleeding on Long-Term Mortality in Percutaneous Coronary Intervention Patients Taking Oral Anticoagulants.
    Ruka Yoshida, H. Ishii, I. Morishima, A. Tanaka, Yasuhiro Morita, K. Takagi, N. Yoshioka, Kenshi Hirayama, N. Iwakawa, Hiroshi Tashiro et al. · 2019 · Journal of Cardiovascular Pharmacology
  51. Intervención coronaria percutánea y anticoagulantes orales
    Juan M. Ruiz-Nodar, Fernando Torres Mezcúa, Cristina Cambra Poveda · 2019 · Revista Española de Cardiología Suplementos
  52. Antiplatelet Effect of a Pulaimab [Anti-GPIIb/IIIa F(ab)2 Injection] Evaluated by a Population Pharmacokinetic-pharmacodynamic Model
    Yaou Liu, Zining Wang, Chaoyang Chen, Xian-Han Zhuang, Changgeng Ruan, Ying Zhou, Yimin Cui · 2019 · Current Drug Metabolism
  53. Triple Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing PCI: Adequate Time in Therapeutic INR Range
    Hirokazu Konishi, Katsumi Miyauchi, Hiroyuki Daida · 2017
  54. Characteristics and outcomes in patients with atrial fibrillation and acute coronary syndrome treated with ticagrelor and novel oral anticoagulants
    Jesper van der Pals, Fredrik Holmqvist, Rasmus Borgquist, Matthias Götberg, Mohaned Nseir, Sasha M. Koul, Nazim Isma, Fredrik Scherstén, Patrik Tydén, Oscar Ö. Braun et al. · 2021 · Thrombosis Update
  55. Predictive models for adverse clinical outcomes in Chinese patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting
    Jianyong Zheng, Yi Cao, Dongtao Li, Yi‐Gang Qiu, Li Zhao, Zhengming Xu, Yi-Xiong Huang, Zhi-Bo Hong, Tianchang Li, Yi‐Da Tang et al. · 2021 · Acta cardiologica. Supplementum
  56. Triple Therapy: Risky but Sometimes Necessary
    Rikke Sørensen, Gunnar Gislason · 2013 · Springer eBooks
  57. Reply
    Renata Rogacka, Alaide Chieffo, Antonio Colombo · 2008 · JACC: Cardiovascular Interventions
  58. Atrial Fibrillation
    Elias B. Hanna · 2017 · Wiley eBooks
  59. The Combination of Anticoagulants and Platelet Inhibitors Postcoronary Stent Implantation
    Hussam Hamdalla, Steven R. Steinhubl · 2009 · Fundamental and clinical cardiology
  60. Triple antithrombotic therapy benefits patients treated for atrial fibrillation
    2008 · Nature Clinical Practice Cardiovascular Medicine
  61. Is thrombogenesis related to residual platelet function in ischaemic heart disease?: reply
    Tsukasa Ohmori, Yuichiro Yano, Kazuyuki Shimada, Kazuomi Kario, Yoichi Sakata · 2008 · European Heart Journal
  62. Tüm Yönleri ile AF ve Tedavi Yaklaşımları
    Aykan Çelik, Aykun Hakgör, Ayşe Çolak, Ayşegül Ülgen Kunak, Burak Sezenöz, Büşra Güvendi Şengör, Can Baba Arın, Ece Çelebi Coşkun, Elif Ilkay Yuce Ersoy, Emrah Aksakal et al. · 2022 · Akademisyen Kitabevi eBooks
  63. Comparison between single and dual antiplatelet therapy in patients on oral anticoagulants undergoing coil embolization for unruptured intracranial aneurysms: a retrospective multicenter cohort study
    Seung Pil Ban, O-Ki Kwon, Young Deok Kim, Hwan Seok Shim, Seung Bin Sung, Jung Cheol Park, Hyoung Soo Byoun, Min Jai Cho, Hyunjun Jo, Hyun Chul Park et al. · 2025 · Neuroradiology
  64. Atrial Fibrillation and Stroke
    Bojana Žvan · 2011 · Hrčak Portal of scientific journals of Croatia (University Computing Centre)
  65. Risques et bénéfices des stratégies associant anticoagulants et antiagrégants plaquettaires chez le patient coronarien
    Mathieu Kernéis · 2020 · theses.fr (ABES)
  66. Clopidogrel vs. Aspirin in Double Antithrombotic Therapy for Patients on Oral Anticoagulation Undergoing Coronary Stenting
    Graziella Pompei, Manfredi Arioti, Carolina Moretti, Francesco Bendandi, Riccardo Panevino, Sebastiano Sanna, Gavino Casu, Andrea Rubboli · 2026 · Journal of Cardiovascular Development and Disease
  67. Precision Medicine for Anticoagulation Strategies in the Cath Lab: Part 2
    Tanawat Attachaipanich, Tania Ahuja, Samin K Sharma, Gregg W. Stone, Chayakrit Krittanawong · 2026 · Current Cardiology Reports
  68. Blood-based biomarkers and major adverse cardiac events after percutaneous coronary intervention: a systematic review with narrative synthesis
    Shyamalendu Tripathy, Minesh Patel · 2026 · Frontiers in Cardiovascular Medicine
  69. Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention: A Nationwide Cohort Study
    Lamberts, Morten, Olesen, Jonas Bjerring, Ruwald, Martin Huth, Hansen, Carolina Malta, Karasoy, Deniz, Kristensen, Søren Lund, Køber, Lars, Torp-Pedersen, Christian, Gislason, Gunnar Hilmar, Hansen, Morten Lock · 2012 · Circulation